Method Development And Validation For Simultaneous Determination Of Sitagliptin Phosphate And Metformin Hydrochloride By RP-HPLC In Bulk And Tablet Dosage Form | 5883
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Method development and validation for simultaneous determination of sitagliptin phosphate and metformin hydrochloride by RP-HPLC in bulk and tablet dosage form

3rd International Conference and Exhibition on Analytical & Bioanalytical Techniques

A.B. Loni

Posters: J Anal Bioanal Techniques

DOI: 10.4172/2155-9872.S1.010

The pyrazole scaffold represents a common motif in many pharmaceutical active and remarkable compounds demonstrating a wide range of pharmacological activities; the most important activities are the anti-inflammatory, the antibacterialantifungal, the hypoglycemic, the anti-hyperlipidemic, the inhibition of cyclooxigenase-2, p38 MAP kinase and CDK2/Cyclin A, and the antiangiogenic. In the present work we are aiming to synthesis novel pyrazole derivatives together with their antitumor evaluations. the reaction of cyanoacetylhydrazine with chloroacetylchloride gave the N-acyl derivative 3. The the latter underwent ready cyclization in sodium ethoxide to give the pyrazole derivative 4 which was the key compound for the synthesis of thiophene, thieno[2,3-b]pridine and thiazole derivatives. The cytotoxicity of the newly synthesized products towards against three human tumor cells lines namely breast adenocarcinoma (MCF 7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268) and some of these compounds were found to exhibit much higher inhibitory effects towards the three tumor cell lines than the reference doxorubicin.
Rafat Mohareb has completed his Ph. D at the age of 26 years from Cairo University. He got full Professer in 1994, participating with International fellows foundations like: the Alexander von Humboldt foundation, Full bright and the Arab-fund Foundation for Social and economic developments. He was published around 125 papers in the field of Pharmaceutical Chemistry.